Urology · Brooklyn, NY
NPI
1437172525
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1773 E 19th St, Ste 1c
Brooklyn, NY, 11229
Phone (718) 676-1180
Groups this clinician bills Medicare through
Medicare paid, 2024
$521K
6,933 services
Medicare patients, 2024
1,317
Average age 77
Drug cost, 2024
$3.9M
15,445 prescriptions
Company payments, 2025
$1,174
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Igor Ryndin was code 99213 (office e&m - established), 1,753 times for 832 patients. In total Igor Ryndin billed 6,933 services in 66 codes, and Medicare paid $521K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,753 | 832 | $71.62 | $126K |
| 99231 Hospital E&M - Subsequent | Facility | 496 | 202 | $39.01 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 481 | 227 | $61.70 | $30K |
| 99233 Hospital E&M - Subsequent | Facility | 403 | 217 | $92.66 | $37K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 377 | 370 | $87.64 | $33K |
| 36415 Venipuncture Blood Collection | Office | 342 | 309 | $8.65 | $2,958 |
| 51741 Test - Miscellaneous | Office | 319 | 290 | $11.03 | $3,519 |
| 76872 Ultrasound - Nonspecific | Office | 296 | 281 | $112.30 | $33K |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 284 | 275 | $82.83 | $24K |
| 99212 Office E&M - Established | Office | 243 | 171 | $45.49 | $11K |
| 88305 Surgical Pathology Examination | Office | 218 | 20 | $29.43 | $6,415 |
| 99203 Office E&M - New | Office | 189 | 189 | $88.14 | $17K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 162 | 27 | $136.19 | $22K |
| 52000 Cystourethroscopy | Office | 155 | 115 | $196.57 | $30K |
| 76870 Ultrasound - Nonspecific | Office | 154 | 152 | $79.84 | $12K |
By year: 2022 $608K for 6,893 services; 2023 $578K for 7,161 services; 2024 $521K for 6,933 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 342 | 309 | $8.65 | $2,958 |
| 88305 Surgical Pathology Examination | 218 | 20 | $29.43 | $6,415 |
| 88112 Surgical Pathology Examination | 109 | 94 | $20.59 | $2,245 |
| 88121 Surgical Pathology Examination | 78 | 70 | $36.01 | $2,809 |
| 88344 Immunohistochemistry | 58 | 17 | $34.44 | $1,998 |
| 88313 Surgical Pathology Examination | 54 | 51 | $9.13 | $493 |
| 88342 Immunohistochemistry | 41 | 39 | $26.05 | $1,068 |
| 88120 Surgical Pathology Examination | 27 | 25 | $43.21 | $1,167 |
Medicare prescription drug claims, 2024
In 2024, the drug Igor Ryndin prescribed most often to Medicare patients was Tamsulosin Hcl, with 4,914 prescriptions and refills. In total Igor Ryndin wrote 15,445 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 4,914 | 11,768 | 1,519 | $94K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 1,621 | 3,785 | 539 | $33K |
| Finasteride Generic | 1,526 | 3,657 | 477 | $14K |
| Gemtesa Vibegron | 1,363 | 1,983 | 361 | $909K |
| Levofloxacin Generic | 687 | 687 | 511 | $3,033 |
| Myrbetriq Mirabegron | 565 | 951 | 150 | $411K |
| Naproxen Generic | 555 | 573 | 261 | $1,757 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 516 | 524 | 367 | $8,819 |
| Silodosin Generic | 475 | 917 | 135 | $42K |
| Ciprofloxacin Hcl Generic | 304 | 304 | 249 | $1,201 |
| Imipramine Hcl Generic | 261 | 547 | 78 | $6,668 |
| Potassium Citrate Er Potassium Citrate | 221 | 450 | 62 | $18K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 202 | 394 | 60 | $2,693 |
| Ciclopirox Ciclopirox Olamine | 176 | 177 | 82 | $3,494 |
| Paroxetine Hcl Generic | 164 | 173 | 40 | $860 |
Brand drugs: 2,451 claims; generic drugs: 12,975 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Igor Ryndin $1,174 ($1,174 in general payments such as food, travel and fees) from 11 companies. The largest payer was Sumitomo Pharma America, Inc. with $783.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 38 | $783 |
| Pfizer Inc. PFE | 4 | $90.37 |
| Azurity Pharmaceuticals, Inc. | 3 | $57.7 |
| Endo USA, Inc. | 2 | $53.6 |
| Astellas Pharma US Inc 4503.T | 2 | $35.02 |
| Olympus America Inc. | 1 | $31.76 |
| Octapharma USA, Inc. | 1 | $31.49 |
| Abbvie Inc. ABBV | 1 | $26.92 |
| ViiV Healthcare Company GSK | 1 | $24.52 |
| SRS Medical Systems, Inc. | 1 | $21.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.